← Back to Search

Anti-tumor agent

PAH Binary Mixture for Environmental Exposures

Phase < 1
Waitlist Available
Research Sponsored by Oregon State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 hours
Awards & highlights

Study Summary

This trial looks at how the body processes a specific type of pollution, and how that changes when there's more pollution present.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Plasma and urine 14C-BaP and 14C-BaP metabolite levels after oral dose
Secondary outcome measures
Area under plasma concentration of 14C-BaP versus time curve AUC
Metabolites of 14C-BaP in plasma
Metabolites of 14C-BaP in urine
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: 50 ng dose plus 1250 ng phenanthreneExperimental Treatment1 Intervention
Capsule containing 50 ng (5.4 nCi) [14C]-benzo[a]pyrene (BaP) and 1250 phenanthrene
Group II: 50 ng doseExperimental Treatment1 Intervention
Capsule containing 50 ng (5.4 nCi) [14C]-benzo[a]pyrene (BaP)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
[14C]-benzo[a]pyrene
2018
Completed Early Phase 1
~20
[14C]-benzo[a]pyrene plus phenanthrene
2018
Completed Early Phase 1
~10

Find a Location

Who is running the clinical trial?

Oregon State UniversityLead Sponsor
49 Previous Clinical Trials
8,376 Total Patients Enrolled
3 Trials studying Environmental Exposures
455 Patients Enrolled for Environmental Exposures
National Institute of Environmental Health Sciences (NIEHS)NIH
284 Previous Clinical Trials
1,232,732 Total Patients Enrolled
12 Trials studying Environmental Exposures
4,761 Patients Enrolled for Environmental Exposures
Lawrence Livermore National LaboratoryOTHER
5 Previous Clinical Trials
88 Total Patients Enrolled
2 Trials studying Environmental Exposures
15 Patients Enrolled for Environmental Exposures

Media Library

[14C]-benzo[a]pyrene (Anti-tumor agent) Clinical Trial Eligibility Overview. Trial Name: NCT03631667 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial actively recruiting participants?

"As documented on clinicaltrials.gov, this particular trial is no longer accepting patients as it was initially posted in October 2018 and last updated April 2022. Nevertheless, 15 other medical studies are proactively recruiting participants at this moment."

Answered by AI

What type of individual is the ideal participant for this trial?

"This trial is searching for up to 5 participants with a history of environmental exposures, aged between 21 and 65."

Answered by AI

Does the age requirement for this trial permit those under 40 to participate?

"This research seeks participants who have reached the age of majority, but are no older than 65."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Ultralow Dose PAH Binary Mixture Study
David Williams 2018. "Ultralow Dose PAH Binary Mixture Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03631667.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top